ArticleBMJ open2026
Understanding the impact, reach and implementation of a health systems intervention to improve diabetes and hypertension care in pluralistic urban public primary care in Bangladesh: a study protocol.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn Bangladesh, government provision of primary care in rural areas has seen the development of services for non-communicable diseases, particularly hypertension and diabetes (given their substantial rise in recent decades). However, in the context of cities, which are characterised by a plurality of providers that have sprung up to meet the demands of a rapidly growing urban population, such provision is very limited. METHODS AND ANALYSIS: We will conduct a mixed-methods study, based on the RE-AIM framework, to understand the (1) reach, (2) effectiveness, (3) adoption, (4) implementation and (5) maintenance (the five RE-AIM domains) of a health systems intervention to strengthen management processes for hypertension and diabetes within government and non-governmental organisation (NGO-run) primary care facilities. To evaluate the effectiveness of the intervention, we will use a quasi-experimental, difference-in-differences design. We will recruit 20 purposively selected urban government-run and NGO-run primary care facilities across Dhaka North and South City Corporation areas. Ten facilities will be purposively allocated to an intervention group and receive training and guidance materials on diabetes and hypertension care, based on the WHO Package of Essential Non-communicable (PEN) Disease Intervention for Primary Care, and the use of an e-health application for patient records. The remaining facilities will be allocated to the existing care group and receive no intervention inputs, with identical data collection processes carried out in both groups. We aim to collect data on 50 patients visiting each facility during a baseline period and at 6 and 12 months after implementing the intervention. We will estimate the average treatment effect on the treated (ATT) for the intervention at 6 and 12 months after implementing the intervention on a primary outcome that measures how many of eight key management processes are appropriately carried out for each patient visit at a study facility (with the appropriateness of each management process determined by assessing criteria based on how patients should be managed according to the intervention guidelines). We will also estimate the ATT for the intervention at 6 and 12 months after implementing the intervention on each of the appropriate management processes making up the primary outcome as separate secondary outcomes. Alongside this design, we will collect a range of additional quantitative and qualitative data to evaluate the other RE-AIM domains, using sequential mixed methods approaches, focusing on understanding potential facilitators and barriers in relation to these domains. ETHICS AND DISSEMINATION: Ethics approval has been received from the Research Governance Committee at the University of Leeds, UK (MREC 21-008) and from the Bangladesh Medical Research Council (BMRCAIREC/20 I 9-2022/485). We will use a variety of channels to share our findings with policy makers, service providers, academicians and relevant stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.